Patents for C07H 21 - Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids (89,892) |
---|
08/28/2003 | WO2003055911A3 Cystine-knot fold protein |
08/28/2003 | WO2003051881B1 Substituted purine nucleoside libraries and compounds by solid-phase combinatorial strategies |
08/28/2003 | WO2003043986A8 Polypeptides of moraxella (branhamella) catarrhalis |
08/28/2003 | WO2003020912A3 Novel clark protein and nucleic acid molecules and uses therefor |
08/28/2003 | WO2003020894A3 Insulin related transcription factor and uses thereof |
08/28/2003 | WO2003002587A3 Phosphoramide containing nucleic acid-based compounds and libraries as antivirals |
08/28/2003 | US20030163845 Elongase genes and uses thereof |
08/28/2003 | US20030162944 Nucleic acid encoding neuropeptide Y/peptide YY (Y2) receptors and uses thereof |
08/28/2003 | US20030162266 When the primers hybridize to each other, the 3' terminal residue of one primer forms a mismatch with the altered or mutated nucleotide residue on the other primer, thus preventing primer extension |
08/28/2003 | US20030162250 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
08/28/2003 | US20030162214 Self-addressable self-assembling microelectronic systems and devices for molecular biological analysis and diagnostics |
08/28/2003 | US20030162213 Terminal-phosphate-labeled nucleotides and methods of use |
08/28/2003 | US20030162201 Cloned DNA polymerases from Thermotoga and mutants thereof |
08/28/2003 | US20030162199 Polymerase chain reactions; by-product inhibition |
08/28/2003 | US20030162198 Medical diagnosis; complexing to Dna; calibration |
08/28/2003 | US20030162185 Products comprising a support to which nucleic acids are fixed and their use as dna chips |
08/28/2003 | US20030162184 Amplification; polymerase chain reactions |
08/28/2003 | US20030162182 Species-specific PCR assay for detection of Leishmania donovani in clinical samples of kala-azar and post kala-azar dermal leishmaniasis |
08/28/2003 | US20030162170 Nucleic acids; antibody, antigen complex |
08/28/2003 | CA2775650A1 Decreased reducing sugars in plants for the reduction of acrylamide production in heated foods |
08/28/2003 | CA2480771A1 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and used thereof |
08/28/2003 | CA2477202A1 Cd40 splice variants, compositions for making and methods of using the same |
08/28/2003 | CA2476437A1 Chemosensitizing with liposomes containing oligonucleotides |
08/28/2003 | CA2476423A1 Conjugates of biologically active compounds, methods for their preparation and use, formulation and pharmaceutical applications thereof |
08/28/2003 | CA2476394A1 Rna interference mediated inhibition of hiv gene expression using short interfering nucleic acid (sina) |
08/28/2003 | CA2476362A1 Chimeric cannulae proteins, nucleic acids encoding them and methods for making and using them |
08/28/2003 | CA2476112A1 Rna interference mediated inhibition of interleukin gene expression using short interfering nucleic acid (sina) |
08/28/2003 | CA2475188A1 Mismatch repair detection |
08/28/2003 | CA2473132A1 Vaccination and vaccine and drug delivery by topical application of vectors and vector extracts recombinant vectors, and noninvasive genetic immunization, expression products therefrom,and uses thereof |
08/28/2003 | CA2459532A1 Rna interference by modified short interfering nucleic acid |
08/28/2003 | CA2456444A1 Rna interference mediated inhibition of vascular endothelial growth factor and vascular endothelial growth factor receptor gene expression using short interfering nucleic acid (sina) |
08/28/2003 | CA2455506A1 Rna interference mediated treatment of alzheimer's disease using short interfering nucleic acid (sina) |
08/28/2003 | CA2418780A1 Synthetic genes encoding proteins of porcine reproductive and respiratory syndrome virus and use thereof |
08/27/2003 | EP1337665A2 Immobilization of biopolymers to aminated substrates by direct adsorption |
08/27/2003 | EP1337641A2 Flea gaba receptor subunit nucleic acid molecules, proteins and uses thereof |
08/27/2003 | EP1337638A2 Adipocyte complement related protein zacrp13 |
08/27/2003 | EP1337546A2 Method for detecting hematopoietic stem cells |
08/27/2003 | EP1337542A2 Method for removing a universal linker from an oligonucleotide |
08/27/2003 | EP1337541A2 Massive parallel method for decoding DNA and RNA |
08/27/2003 | EP1169046B1 Pulmonary delivery of protonated/acidified nucleic acids |
08/27/2003 | EP0750458B1 Terminal complement inhibitor fusion genes and proteins |
08/27/2003 | CN1438235A Pure honeysuckle polymerase chain reaction-restriction map identification method |
08/27/2003 | CN1438234A Potato 1-amino-cyclopropane-1-carboxylic-synthesized zyme gene chip and primer |
08/27/2003 | CN1438233A Tomato 1-amino-cyclopropane-1-carboxylic-synthesized zyme gene chip and primer |
08/27/2003 | CN1438232A Maize alcohol soluble protein gene chip and primer |
08/27/2003 | CN1438231A Soybean 1-amino-cyclopropane-1-carboxylic-synthesized zyme gene chip and primer |
08/27/2003 | CN1438230A Nucleotide |
08/27/2003 | CN1438229A nucleotide and its use |
08/27/2003 | CN1119169C Tumor rejection antigens presented by HLA-B44 molecules, and uses thereof |
08/26/2003 | US6610842 Removing hydroxyl protecting group from compound of given formula and treating with another compound; wide range of diagnostic and therapeutic uses |
08/26/2003 | US6610837 Preparation of an oligonucleotide compound of given formula by reacting with given compounds, followed by oxidation or sulfurization |
08/26/2003 | US6610829 Human extracellular matrix-1 |
08/26/2003 | US6610663 Antisense compound with targeting and RNA cleaving moieties, preferably an imidazole functionality conjugated to the targeting oligonucleotide via linkers |
08/26/2003 | US6610650 Modulation of cellular transcription factor activity |
08/26/2003 | US6610536 Nucleic acids and polypeptides |
08/26/2003 | US6610522 Cloned genes encoding reverse transcriptase lacking RNase H activity |
08/26/2003 | US6610513 Receptor proteins |
08/26/2003 | US6610492 The present invention is directed to novel base-modified nucleotides and methods for their use in the preparation and cleavage of modified polynucleotides. |
08/26/2003 | US6610491 Detecting preferential nucleotide sequences in sample; obtain oligonucleotides, incubate with nucleotide sequence sample, detect hybridization |
08/26/2003 | US6610482 Sequencing, fingerprinting and mapping biological macromolecules, typically biological polymers. The methods make use of a plurality of sequence specific recognition reagents which can also be used for classification of |
08/26/2003 | US6610475 Kits for processing biological specimens for nucleic acid hybridization assays, target amplification reactions and similar uses |
08/26/2003 | CA2115342C A method of detecting and discriminating between nucleic acid sequences |
08/21/2003 | WO2003069306A2 Protein carrier system for therapeutic oligonucleotides |
08/21/2003 | WO2003068940A2 Complexes and methods of using same |
08/21/2003 | WO2003068911A2 Citrus tristeza virus resistance genes and methods of use |
08/21/2003 | WO2003068798A2 Oligonucleotide analogues and methods of use for modulating gene expression |
08/21/2003 | WO2003068795A1 Nucleoside analogues and oligonucleotide derivative comprising nucleotide analogue thereof |
08/21/2003 | WO2003068787A1 Bi-functionalised metallocenes use for marking biological molecules |
08/21/2003 | WO2003060142A9 Compositions and methods for controlled release |
08/21/2003 | WO2003055913A3 Secreted protein |
08/21/2003 | WO2003051897B1 Nucleoside analog libraries and compounds |
08/21/2003 | WO2003008550A3 Synthesis of oligonucleotides on solid supports including non-reactive solid diluents |
08/21/2003 | WO2003008539A3 Non-alloying core shell nanoparticles |
08/21/2003 | WO2003004686A3 Fluorescence-based assay for the detection of specific nucleic acids using photon counting |
08/21/2003 | WO2002072140A3 Mhc-i-restricted presentation of hiv-1 virion antigens without viral replication. application to the stimulation of ctl and vaccination in vivo; analysis of vaccinating composition in vitro |
08/21/2003 | WO2002033128A3 Multiplex quantification of nucleic acids in diseased cells |
08/21/2003 | WO2002022882A3 Target activated nucleic acid biosensor and methods of using same |
08/21/2003 | WO2002008453A3 Canine toxicity genes |
08/21/2003 | WO2002008446A9 Synthesis and antiviral evaluation of nucleic acid based (nab) libraries |
08/21/2003 | US20030158407 A Fluorescent dyes for labelling biopolymers and cell surface, a conjugated with polynucleotides or nucleotides |
08/21/2003 | US20030158403 Nuclease resistant chimeric oligonucleotides |
08/21/2003 | US20030158398 Central nervous system disorders; psychological disorders |
08/21/2003 | US20030158381 Novel insulin/igf/relaxin family polypeptides and dnas thereof |
08/21/2003 | US20030158135 Derived from staphylococcal genes; use of the polynucleotides as oligonucleotide primers or probes for detecting Staphylococcal strains that are resistant to streptogramin A or streptogramin B and related compounds in biological sample |
08/21/2003 | US20030158104 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
08/21/2003 | US20030157705 Engineered recombinant molecule that regulates humoral and cellular effector functions of the immune system |
08/21/2003 | US20030157687 Comprises nucleotide sequences coding enzyme inhibitor (TIMP-4) for treatment of arthritis, cancer and scarring |
08/21/2003 | US20030157681 For use in therapeutics and diagnostic formulations |
08/21/2003 | US20030157643 Synthetic nucleic acids from aquatic species |
08/21/2003 | US20030157632 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
08/21/2003 | US20030157631 For stimulating release of tumor necrosis factor and/or cellular proliferation/differentiation of chondrocytes/adipocytes/endothelial cells by contacting blood with pro-polypeptide; tumor diagnosis |
08/21/2003 | US20030157630 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
08/21/2003 | US20030157629 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
08/21/2003 | US20030157628 For stimulating release of tumor necrosis factor and/or cellular proliferation/differentiation of chondrocytes/adipocytes/endothelial cells by contacting blood with pro-polypeptide; tumor diagnosis |
08/21/2003 | US20030157627 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
08/21/2003 | US20030157626 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
08/21/2003 | US20030157624 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
08/21/2003 | US20030157623 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
08/21/2003 | US20030157622 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
08/21/2003 | US20030157621 Secreted and transmembrane polypeptides and nucleic acids encoding the same |